ArticleOncoimmunology2016

Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.

Kei Ishibashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.